BCR Back

breakpoint cluster region

External References:      Wikipedia GeneCards HUGO COSMIC Google Scholar

NCBI Description of BCR
A reciprocal translocation between chromosomes 22 and 9 produces the Philadelphia chromosome, which is often found in patients with chronic myelogenous leukemia. The chromosome 22 breakpoint for this translocation is located within the BCR gene. The translocation produces a fusion protein which is encoded by sequence from both BCR and ABL, the gene at the chromosome 9 breakpoint. Although the BCR-ABL fusion protein has been extensively studied, the function of the normal BCR gene product is not clear. The protein has serine/threonine kinase activity and is a GTPase-activating protein for p21rac. Two transcript variants encoding different isoforms have been found for this gene.

Community Annotation of BCR Add / Edit BCR: Annotations

No community annotations yet for BCR.
Sort mutations by: Tumor type  Mutation type  Position  
Straightedge cursor Expand

Figure notes


• "Mouse over" a mutation to see details.
• Missense green saturation indicates evolutionary conservation of the mutated positions.
• Red hashes in protein strip are splice sites.
• Blue-white-red bars are log2 copy ratio distributions (–1 to +1) from Zack et al. (2013).


Legend

BCR is highly significantly mutated in
(none)
BCR is significantly mutated in
(none)
BCR is near significance in
(none)

Click on a tumor type to see its full list of significant genes.

Data details


• Mutation list for BCR